DiviScan — Global Health Intelligence Operating System USPTO Prov. #63/706,309
Trial Intelligence Report — paid pilot offering Prepared: July 2026

← Back to DiviScan

Trial Intelligence Report — Paid Pilot Offering ($25K–$100K)

What a Trial Intelligence Report Is

A Trial Intelligence Report is a forward-looking decision artifact built on HyperCore, DiviScan's 320-classifier ensemble. Take a publicly disclosed phase 2 or phase 3 overall-survival (OS) dataset, decompose the Kaplan-Meier (KM) curve into inflection regimes, score each patient on the responder / non-responder boundary at the inflection, and surface the classifiers that drive the boundary. The deliverable pairs that decomposition with a decision narrative — readable in a single pass by a Tier 1 reviewer — that frames the conversation toward the next trial design, the next regulatory engagement, or the next label-expansion move.

The Decomposition Stack

320 classifiers
HyperCore ensemble · KM curve · Responder attribution

HyperCore's 320-classifier ensemble scores each patient against the inflection-labeled boundary the KM decomposition exposes. Top-12 feature weights are normalized to sum ≈ 1.00 and listed auditable. The same decomposition extends across a comparator set for multi-trial briefs.

Why forward-looking framing matters. A Tier 1 audience buys time, not deliverables. Each Trial Intelligence Report is engineered as a conversation-opener whose natural finish-line is a paid follow-on (the validate-on-your-data pilot). Retrospective critique gains trust; forward-looking framing converts it.

Three Engagement Tiers — Sample-Range $25K–$100K

Pricing is per trial-set scope, durable separation depth, and turnaround. All three tiers deliver the same HyperCore 320-classifier decomposition; the difference is breadth, depth of comparative narrative, and the size of the working session.

TIER 1 · $25K
Focused Single-Trial KM Report
4-page artifact. A single trial: KM decomposition with the inflection labeled, top-12 classifier attribution, decision implications. Modeled on the existing KEYNOTE-789 sample. 4-week turnaround. Best fit when one trial is the live conversation and the label-expansion question is sharp.
TIER 2 · $60K
Multi-Trial Comparative Brief
8-page artifact. Side-by-side decomposition of 2–3 trials from the same class or label-expansion neighborhood, classifier attribution across the comparator set, and a label-expansion comparison narrative. 6-week turnaround. Best fit when the conversation is a portfolio positioning question — how your asset reads against peers.
TIER 3 · $100K
Engagement-Scope Pilot
12-page artifact. The full decision narrative, including one in-person working session with the program team and one round of revisions against your team's read. Forward-looking framing against your next trial design or regulatory engagement. 6–8-week turnaround. Best fit when a single decision is on the table — CDx scope, label-expansion filing posture, or a comparator design question.

Pricing scoped within the $25K–$100K pilot band per the published roadmap. Engagement-specific scope changes are quoted after a 30-minute scoping call. Pilot engagements are fixed-bid; follow-on work is time-and-materials.

Every Engagement Ships Three Artifacts

Each Trial Intelligence Report ships in three formats so the reviewer can read however they read. The KEYNOTE-789 sample below mirrors what a completed Tier 1 deliverable actually looks like.

Artifact Format What It Contains Sample (KEYNOTE-789)
HTML Self-contained 4-page printable Numbered pages, inline SVG KM chart, classifier table, impl-points section, decision narrative. Designed for first-pass Tier 1 review. /keynote-789-report
CSV Auditable raw data KM curves (24 monthly rows per arm) plus classifier-attribution table with weights, direction, classifier IDs, and notes. Importable into R, Python, or Excel for re-analysis. /keynote-789-trial-intelligence-report-data.csv
Markdown Version-controlled narrative Page-by-page decision narrative with editorial hooks, decision-implications section, and a closing paid-pilot CTA. Diff-able across report revisions. /keynote-789-trial-intelligence-report.md

All three formats ship on the same day. CSV and markdown are auditable companions to the HTML — reviewers who want to re-derive the chart or check the classifier weights against their own read can do so without leaving the engagement scope.

Read the KEYNOTE-789 Sample Before You Engage

The KEYNOTE-789 sample Trial Intelligence Report is a completed Tier 1 deliverable — same decomposition stack, same artifact set, same narrative structure that ships from a paid engagement. Read it end-to-end before scoping a pilot; that's the audit you should perform on the methodology before committing a quarter's worth of label-expansion conversation to it.

View the live KEYNOTE-789 sample report → /keynote-789-report. The sample comprises: a 4-page HTML report with an inline KM chart and the month-9 inflection guide; a 24-row-per-arm CSV (48 rows of KM + 12 classifier-attribution rows); and a markdown narrative that mirrors the decision-implications framing a paid deliverable would ship. Reviewer scope: 8–12 minutes first-pass; 30–45 minutes with the CSV open alongside.

Browse the full sample library. Both KEYNOTE-789 and the Tier 1 Evidence Package are listed in one place → /library. Read either sample end-to-end before scoping, or scan both side-by-side to compare the Tier 1 pilot deliverable shape against the due-diligence evidence package.

Request a Pilot Engagement

Send name, organization, role, and the trial or trial-set you'd like decomposed. We respond within one business day with a scoping read (which tier fits, which publicly disclosed dataset is intact enough to run on, and what the 4–6-week window looks like from kickoff). No NDAs required to scope; NDAs only if you want tier-3 with an in-person session.

What happens after you request. Your row lands in lead_captures, and we respond with a scoping read within one business day. The lead form runs on the pitch page so you can read the sample you picked without leaving the page.